Description: - 400 active small molecules associated with cuproptosis for high-throughput and high-intensity screening.- Targeting Ferredoxin 1 (FDX1), Antioxidant 1 Copper Chaperone (ATOX1), CCS (copper chaperones), mitochondrial respiration, etc.- Some compounds are FDA-approved.- Detailed instructions, compound structure, target information, description of activity, etc.- Various detection techniques such as NMR, HPLC/LCMS to ensure the correct structure and high purity of the product and reduce false positives.